Archives of Clinical Infectious Diseases

Published by: Kowsar

Evaluation of Serum Level of Interleukin-6 in Patients With Crimean-Congo Hemorrhagic Fever in Zahedan, Iran, From 2012 to 2015

Seyed Mohammad Hashemi Shahri 1 , Javid Dehghan 1 , Zakaria Bameri 1 , Abdolhadi Kor 1 , Batool Sharifi Mood 1 , * and Masoud Mardani 2
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: July 01, 2016, 11 (3); e28029
  • Published Online: June 26, 2016
  • Article Type: Research Article
  • Received: February 17, 2015
  • Revised: May 16, 2016
  • Accepted: May 29, 2016
  • DOI: 10.5812/archcid.28029

To Cite: Hashemi Shahri S M, Dehghan J, Bameri Z, Kor A, Sharifi Mood B, et al. Evaluation of Serum Level of Interleukin-6 in Patients With Crimean-Congo Hemorrhagic Fever in Zahedan, Iran, From 2012 to 2015, Arch Clin Infect Dis. 2016 ; 11(3):e28029. doi: 10.5812/archcid.28029.

Abstract
Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Keshtkar-Jahromi M, Sajadi MM, Ansari H, Mardani M, Holakouie-Naieni K. Crimean-Congo hemorrhagic fever in Iran. Antiviral Res. 2013; 100(1): 20-8[DOI][PubMed]
  • 2. Sharifi-Mood B, Metanat M, Alavi-Naini R. Prevalence of crimean-congo hemorrhagic Fever among high risk human groups. Int J High Risk Behav Addict. 2014; 3(1)[DOI][PubMed]
  • 3. Sharifi-Mood B, Mardani M, Keshtkar-Jahromi M, Rahnavardi M, Hatami H, Metanat M. Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J. 2008; 27(6): 561-3[DOI][PubMed]
  • 4. Sharifi-Mood B, Metanat M, Ghorbani-Vaghei A, Fayyaz-Jahani F, Akrami E. The Outcome of Patients with Crimean-Congo Hemorrhagic Fever in Zahedan, southeast of Iran: A Comparative Study . Arch Iranian Med. 2009; 12(2)
  • 5. Hashemi-Shahri S, Sharifi-Mood B, Metant M. Risk Factors Associated With Poor Prognosis in Children With Crimean-Congo Hemorrhagic Fever. Int J Infect. 2014; 1(3): 7-12
  • 6. Chinikar S. An overview of Crimean-Congo Hemorrhagic Fever in Iran. Iranian J Microbiol. 2009; 1(1): 7-12
  • 7. Mardani M, Rahnavardi M, Rajaeinejad M, Naini KH, Chinikar S, Pourmalek F, et al. Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions. Am J Trop Med Hyg. 2007; 76(3): 443-5[PubMed]
  • 8. Mardani M, Keshtkar-Jahromi M, Ataie B, Adibi P. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am J Trop Med Hyg. 2009; 81(4): 675-8[DOI][PubMed]
  • 9. Chinikar S, Ghiasi SM, Moradi M, Goya MM, Shirzadi MR, Zeinali M, et al. Geographical distribution and surveillance of Crimean-Congo hemorrhagic fever in Iran. Vector Borne Zoonotic Dis. 2010; 10(7): 705-8[DOI][PubMed]
  • 10. Keshtkar Jahromi M. Crimean-Congo Hemorrhagic Fever-Treatment and Preventive Strategies. Int J Infect. 2014; 1(2)
  • 11. Anderson R, Wang S, Osiowy C, Issekutz AC. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol. 1997; 71(6): 4226-32[PubMed]
  • 12. Schnittler HJ, Feldmann H. Viral hemorrhagic fever--a vascular disease? Thromb Haemost. 2003; 89(6): 967-72[DOI][PubMed]
  • 13. Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia. 2004; 47(3): 532-6[DOI][PubMed]
  • 14. Connolly-Andersen AM, Moll G, Andersson C, Akerstrom S, Karlberg H, Douagi I, et al. Crimean-Congo hemorrhagic fever virus activates endothelial cells. J Virol. 2011; 85(15): 7766-74[DOI][PubMed]
  • 15. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006; 193(7): 941-4[DOI][PubMed]
  • 16. Sancakdar E, Guven AS, Uysal EB, Kaya A, Deveci K, Karapinar H, et al. Evaluation of cytokines as Th1/Th2 markers in pathogenesis of children with Crimean-Congo hemorrhagic fever. Int J Clin Exp Med. 2014; 7(3): 751-7[PubMed]
  • 17. Kaya S, Elaldi N, Kubar A, Gursoy N, Yilmaz M, Karakus G, et al. Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-alpha, IL-6, IL-10, and IFN-gamma levels in patients with Crimean-Congo hemorrhagic fever. BMC Infect Dis. 2014; 14: 416[DOI][PubMed]
  • 18. Deveci K, Oflaz MB, Sancakdar E, Uysal EB, Guven AS, Kaya A, et al. Evaluation of the serum levels of soluble IL-2 receptor and endothelin-1 in children with Crimean-Congo hemorrhagic fever. APMIS. 2014; 122(7): 643-7[DOI][PubMed]
  • 19. Ozsurekci Y, Arasli M, Karadag Oncel E, Caglayik DY, Kaya A, Icagasioglu FD, et al. Can the mild clinical course of crimean-congo hemorrhagic fever in children be explained by cytokine responses? J Med Virol. 2013; 85(11): 1955-9[DOI][PubMed]
  • 20. Dokuzoguz B, Celikbas AK, Gok SE, Baykam N, Eroglu MN, Ergonul O. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin Infect Dis. 2013; 57(9): 1270-4[DOI][PubMed]
  • 21. Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med. 2004; 32: 2416-21
  • 22. Bente DA, Alimonti JB, Shieh WJ, Camus G, Stroher U, Zaki S, et al. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol. 2010; 84: 11089-100
  • 23. Bakir M, Engin A, Gozel MG, Elaldi N, Kilickap S, Cinar Z. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis. 2012; 49(2): 105-10[PubMed]
  • 24. Cevik MA, Erbay A, Bodur H, Eren SS, Akinci E, Sener K, et al. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis. 2007; 45(7)-100[DOI][PubMed]
  • 25. Dewi BE, Takasaki T, Kurane I. Peripheral blood mononuclear cells increase the permeability of dengue virus-infected endothelial cells in association with downregulation of vascular endothelial cadherin. J Gen Virol. 2008; 89: 642-52[DOI][PubMed]
  • 26. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol. 2006; 36(4): 272-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments